Delivery Order SPE2DE24D0013-SPE2D626F14VU
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a $5,440 firm fixed-price delivery order to Cepheid Inc. on January 13, 2026, with an ultimate completion date of January 21, 2026. This delivery order, identified as XPRS4PLEX-10, is a child contract issued under Cepheid's existing Indefinite Delivery Contract with the Department of Veterans Affairs VISN 6, valued at $32.8 million and extending through September 30, 2030. The contract involves the supply of molecular diagnostic testing...
- The Defense Logistics Agency Medical Supply Chain awarded a $40.8K firm fixed-price delivery order to Cepheid Inc. on January 13, 2026, with an ultimate completion date of January 21, 2026. This delivery order, designated as XPRS4PLEX-10, represents a child contract under Cepheid's broader indefinite delivery vehicle with the Department of Veterans Affairs VISN 6, valued at $32.8M and extending through September 30, 2030. The award carries no set-aside designation and is for the provision of...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a $8,160 delivery order (4570311575 | XPRS4PLEX-10) by the Defense Logistics Agency's Medical Supply Chain on December 15, 2025, with an ultimate completion date of December 22, 2025. This firm fixed-price delivery order, which carries no set-aside designation, falls under a larger single-award Indefinite Delivery Contract valued at $6.7 million with the Department of Veterans...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $20,350 by the Defense Logistics Agency Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 20, 2026. This delivery order, designated as XPRS4PLEX-10, represents a child contract under Cepheid's larger Indefinite Delivery Contract vehicle with the Veterans Health Administration VISN 6, valued at $32.8 million and extending through September 30, 2030. The...
- On January 15, 2026, the Defense Logistics Agency Medical Supply Chain awarded a $20.4K delivery order (4570533435) to Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems and reagents. This firm fixed-price delivery order, with an ultimate completion date of January 23, 2026, represents a child contract under Cepheid's larger Indefinite Delivery Contract framework with the Department of Veterans Affairs. The award carries no set-aside designation,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems, was awarded a $1,694 firm fixed-price delivery order (Contract No. XPRS-COV2-10) by the Defense Logistics Agency Medical Supply Chain on January 7, 2026. The delivery order, with an ultimate completion date of January 14, 2026, is issued under Cepheid's existing Indefinite Delivery Contract with the Veterans Health Administration VISN 17, valued at $6.7 million through December 28, 2029. The award carries...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $34,000 firm fixed-price delivery order (Contract 4570371726, XPRS4PLEX-10) by the Defense Logistics Agency Medical Supply Chain on December 29, 2025, with an ultimate completion date of January 6, 2026. This delivery order, which carries no set-aside designation, is issued under Cepheid's existing Indefinite Delivery Contract with the Department of Veterans Affairs Veterans Integrated Service Network (VISN) 17, valued at...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a $2,040 firm fixed-price delivery order (4570331464 | XPRS4PLEX-10) by the Defense Logistics Agency Medical Supply Chain on December 19, 2025, with an ultimate completion date of December 29, 2025. This delivery order, which carries no set-aside designation, is issued under Cepheid's larger Indefinite Delivery Contract with the Department of Veterans Affairs VISN 17, valued at $6.7...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $8,160 to Cepheid Inc. on January 14, 2026, for diagnostic testing supplies under the XPRS4PLEX-10 contract vehicle. This firm fixed-price delivery order, with an ultimate completion date of January 22, 2026, represents a child order issued against Cepheid's larger Indefinite Delivery Contracts with the Department of Veterans Affairs. The award carries no set-aside designation, reflecting Cepheid's competitive...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $6,800 firm fixed-price delivery order to Cepheid Inc. on January 14, 2026, under contract number 4570533423 (XPRS4PLEX-10). This delivery order is a child contract issued under one of Cepheid's existing Indefinite Delivery Contracts with the Department of Veterans Affairs. The order calls for the delivery of XPRS4PLEX-10 cartridges and related molecular diagnostic testing reagents and assays designed for use with Cepheid's...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F14VUDelivery Order
The Defense Logistics Agency Medical Supply Chain awarded a $2,040 firm fixed-price delivery order to Cepheid Inc. on January 20, 2026, with an ultimate completion date of January 27, 2026. This delivery order, designated XPRS4PLEX-10, represents a child contract under Cepheid's larger Indefinite Delivery Contract framework with the Department of Veterans Affairs Veterans Integrated Service Network (VISN) 17, valued at $6.74 million through December 28, 2029. The delivery order procures diagnostic reagents and test kits specifically for the GeneXpert diagnostic platform, including XPRS4PLEX-10 cartridges designed for detecting multiple respiratory pathogens. No small business set-aside was utilized for this award, reflecting Cepheid's competitive positioning as a primary federal supplier of molecular diagnostic solutions. Cepheid, headquartered in Sunnyvale, California, is an established federal contractor specializing in advanced molecular diagnostic systems and reagents for infectious diseases. The company has extensive experience serving federal healthcare agencies including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and the U.S. Coast Guard, with particular expertise in providing rapid molecular diagnostic testing for COVID-19, influenza, respiratory syncytial virus, and tuberculosis. The award supports the federal government's ongoing diagnostic testing capabilities and reflects the continued reliance of federal medical facilities on Cepheid's GeneXpert platform for point-of-care molecular diagnostics across the VA's distributed network of medical centers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 1/19/26 |